Analysts See $0.29 EPS for Merit Medical Systems, Inc. (MMSI)

July 18, 2017 - By Darrin Black

 Analysts See $0.29 EPS for Merit Medical Systems, Inc. (MMSI)
Investors sentiment decreased to 0.88 in 2016 Q4. Its down 0.03, from 0.91 in 2016Q3. It worsened, as 24 investors sold Merit Medical Systems, Inc. shares while 58 reduced holdings. 19 funds opened positions while 53 raised stakes. 39.62 million shares or 0.24% more from 39.52 million shares in 2016Q3 were reported.
88,746 are held by Columbia L L C Invest Management. Blackrock Grp Ltd invested in 263,315 shares or 0% of the stock. Panagora Asset Management owns 0.01% invested in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 78,374 shares. The Missouri-based Century Incorporated has invested 0.01% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Loomis Sayles & Ltd Partnership has invested 0.05% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Ameriprise Finance has invested 0.02% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Fmr Ltd holds 0% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 729,293 shares. State Of Tennessee Treasury Department reported 34,513 shares. First Mercantile reported 5,227 shares. California State Teachers Retirement owns 88,739 shares. Rhumbline Advisers has invested 0% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Eagle Boston Invest owns 586,163 shares for 1.85% of their portfolio. Us Bankshares De holds 26,715 shares. Commercial Bank Of America De holds 0% or 122,727 shares. 8,242 are owned by Bnp Paribas Arbitrage Sa.

Since May 15, 2017, it had 0 buys, and 3 selling transactions for $1.67 million activity. STILLABOWER MICHAEL E had sold 17,110 shares worth $576,799. $551,315 worth of Merit Medical Systems, Inc. (NASDAQ:MMSI) shares were sold by EDELMAN RICHARD W.

Analysts await Merit Medical Systems, Inc. (NASDAQ:MMSI) to report earnings on July, 26. They expect $0.29 earnings per share, up 11.54 % or $0.03 from last year’s $0.26 per share. MMSI’s profit will be $14.83M for 32.37 P/E if the $0.29 EPS becomes a reality. After $0.28 actual earnings per share reported by Merit Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 3.57 % EPS growth. It closed at $37.55 lastly. It is up 81.84% since July 18, 2016 and is uptrending. It has outperformed by 65.14% the S&P500.

Merit Medical Systems, Inc. (NASDAQ:MMSI) Ratings Coverage

Among 5 analysts covering Merit Medical (NASDAQ:MMSI), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Merit Medical had 7 analyst reports since October 23, 2015 according to SRatingsIntel. Barrington Research upgraded it to “Outperform” rating and $22 target in Monday, October 26 report. Canaccord Genuity initiated the stock with “Buy” rating in Tuesday, July 19 report. The stock of Merit Medical Systems, Inc. (NASDAQ:MMSI) earned “Mkt Perform” rating by Barrington Research on Friday, October 23. The stock of Merit Medical Systems, Inc. (NASDAQ:MMSI) has “Buy” rating given on Monday, July 10 by Canaccord Genuity.

Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The company has market cap of $1.92 billion. The Firm operates in two divisions: cardiovascular and endoscopy. It has a 55.71 P/E ratio. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management , electrophysiology (EP), and interventional oncology and spine devices.

More recent Merit Medical Systems, Inc. (NASDAQ:MMSI) news were published by: which released: “Merit Medical Systems to Announce Second Quarter Results on July 26, 2017” on July 10, 2017. Also published the news titled: “Merit Medical Embosphere Gets FDA de novo Classification” on June 26, 2017.‘s news article titled: “Ami Asset Management Corp Buys Henry Schein Inc, West Pharmaceutical Services …” with publication date: July 14, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.